Glow Blend

$190.00

GHK-CU (50mg) | BPC-157 (10mg) | TB500 (10mg)

Glow Blend is a research-only peptide formulation containing GHK-Cu (50mg), BPC-157 (10mg), and TB-500 (10mg), carefully combined to support studies in tissue repair, skin rejuvenation, and cellular regeneration. Each component in this blend has been independently investigated for its role in promoting healthy extracellular matrix function, cellular migration, and wound response mechanisms.

GHK-Cu is a copper-binding peptide widely researched for its potential influence on collagen synthesis, skin remodeling, and antioxidant activity. BPC-157, a pentadecapeptide derived from a gastric protein, has been studied in models for its role in promoting angiogenesis and cellular migration. TB-500, a synthetic version of thymosin beta-4, is often researched for its potential role in tissue recovery and inflammation modulation.

Glow Blend delivers a potent triad of research peptides for laboratories interested in exploring synergistic cellular interactions and regenerative pathways. It is provided as a lyophilized powder and intended strictly for scientific study under controlled conditions.

0% 1 - 4 $190.00
10% 5 - 9 $171.00
20% 10 + $152.00
  • Free shipping on orders over $200
  • Discounts: Calculated in cart.

Description

Glow Blend is a uniquely designed research peptide combination featuring three prominent peptides: GHK-Cu, BPC-157, and TB-500. This synergistic formulation is intended to provide researchers with a robust tool to explore complex biological processes related to skin regeneration, tissue healing, and cellular function regulation.

GHK-Cu (27mg) is a naturally occurring copper peptide known for its high affinity to bind copper ions. It has been widely investigated for its role in modulating gene expression related to tissue repair, collagen production, and antioxidant defense. Research indicates that GHK-Cu may influence fibroblast activity, angiogenesis, and wound repair processes in various in vitro and in vivo models.

BPC-157 (5mg) is derived from a protective gastric peptide sequence and has been the subject of numerous preclinical studies. It has shown promise in research focused on promoting tissue regeneration, reducing inflammation, and enhancing angiogenesis. Its stability and effectiveness in gastrointestinal and musculoskeletal models make it a valuable candidate for ongoing investigation into systemic healing responses.

TB-500 (10mg), a synthetic analog of thymosin beta-4, is a naturally occurring peptide linked with actin binding and cellular motility. It has been studied in models of injury recovery, where it appears to play a role in reducing fibrosis and supporting tissue regeneration. TB-500 may also contribute to cellular migration and angiogenic pathways in preclinical environments.

Glow Blend offers an optimized ratio of these three peptides for experimental use. Each peptide is included in dosages often explored in animal models, allowing for the study of individual and collective mechanisms involved in cellular signaling, matrix support, and repair responses. The lyophilized powder is suitable for reconstitution with bacteriostatic water or sterile solvents and should be stored under proper lab conditions.

Product Data:

  • Composition:
    • GHK-Cu – 27mg
    • BPC-157 – 5mg
    • TB-500 – 10mg
  • CAS Numbers:
    • GHK-Cu: 89030-95-5
    • BPC-157: 137525-51-0
    • TB-500: 77591-33-4

Research

The Glow Blend formulation has been designed to support advanced research into regenerative biology and dermal science. Each of the three peptides — GHK-Cu, BPC-157, and TB-500 — contributes distinct mechanistic effects that may complement one another when studied in combination.

GHK-Cu has been at the forefront of cosmetic and therapeutic peptide research for decades. It is associated with the activation of regenerative genes, stimulation of collagen and glycosaminoglycan synthesis, and the modulation of inflammation in wound-healing studies. Research suggests that GHK-Cu may rejuvenate fibroblasts and stimulate tissue remodeling, making it a focus of skin aging and tissue repair studies.

BPC-157 has shown remarkable effects in rodent models relating to tendon and muscle injury, inflammation suppression, and even nerve regeneration. It is thought to influence angiogenesis via the VEGF pathway and improve cellular migration to the injury site. Studies have also explored its gastroprotective qualities and systemic healing potential, though its mechanisms are still under investigation.

TB-500, as a synthetic form of thymosin beta-4, is primarily known for its actin-regulating capabilities. Actin plays a fundamental role in cell shape, migration, and division. TB-500 has been observed in research models to reduce scar tissue formation, support vascular development, and assist in the repair of damaged cardiac and skeletal muscle tissue.

When studied together, the combination of these peptides allows for exploration into synergistic mechanisms—such as enhanced fibroblast proliferation, collagen and elastin production, and improved microvascular density. This makes Glow Blend a compelling candidate for use in research models of dermal injury, cosmetic aging, and tissue recovery.

It is important to note that all existing studies have been conducted in preclinical or laboratory environments. Glow Blend is not approved for clinical use and should never be administered to humans. All research should be conducted by qualified professionals in accordance with institutional safety protocols and applicable laws.

References:

  1. T. Huang et al., “Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro,” Drug Des. Devel. Ther., vol. 9, pp. 2485–2499, 2015.
  2. Chest. 2006 Nov;130(5):1433-40.  Thymosin beta4 sequesters actin in cystic fibrosis sputum and decreases sputum cohesivity in vitro. Rubin BK1Kater APGoldstein AL.
  3. L. Pickart, J. M. Vasquez-Soltero, and A. Margolina, “GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration,” BioMed Res. Int., vol. 2015, p. 648108, 2015. [BioMed Research International]

 

 

Shopping Cart
Scroll to Top
0